Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05281757

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex

Multicenter, multinational Post-Market Clinical Follow-Up (PMCF) study on the safety and performance of Ennovate® Complex - A prospective, pure data collection of all Ennovate® scoliosis patients in selected centers (not interventional, multicentric)

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Brno, Brno, Czechia

Loading trial locations.

About this study

This clinical study is one of the Post-Market Clinical Follow-Up (PMCF) measures that enables the manufacturer to monitor the clinical safety and performance of the Ennovate® Complex system.

The study enables a quick, but detailed implant documentation, which is of great interest for the current and future users of the internal fixation system targeted in this study. It includes the relevant outcomes to evaluate safety and efficacy of the implant system for various indications in deformity disorders.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed consent in the documentation of clinical and radiological results of patients who are minimum 18 years old
  • Informed consent in the documentation of clinical and radiological results of patients AND legal representative (parent) for patients who are younger than 18
  • Patient's indication according to IFU
  • Patient is not pregnant

Exclusion criteria

  • Patient's clear unability or unwillingness to participate in follow-up examinations

Treatment and study plan

posterior stabilization for the cervical spine

Device

The Ennovate® Complex Spinal System is a posterior stabilization for the Complex and upper-thoracic spine. The implants are used for the posterior multisegmental correction and stabilization over all sections of the spine.

Primary outcomes

  1. Change of Pain

    Time frame: preoperatively, at 3-4 months postoperatively and at approximately 12 and 24 months postoperatively

    ain will be assessed by the patient using the Visual Analogue Scale (VAS) which state "0" at one end representing "no pain" and "100" at the opposite end representing "maximal / worst pain".

Secondary outcomes

  1. Change of Quality of Life

    Time frame: preoperatively, at 3-4 months postoperatively and at approximately 12 and 24 months postoperatively

    In order to analyze the quality of life of the patients, the most current questionnaire of the Scoliosis Research Society (SRS), the "SRS-30" is used. The SRS-30 demonstrates how spinal conditions impact quality of life and facilitate comparisons of the quality of life before and after surgical intervention. It is widely used in the evaluation of the treatment of idiopathic scoliosis patients. SRS-30 is a patient self administered questionnaire and has a minimum score of 30 and a maximum score of 150 including postsurgery questions. Each question is scored on 1-5 scale. Questions are sorted into different domains and total and mean scores for each domain are calculated. A total score for the entire questionnaire is also calculated.

  2. Change of Every day life

    Time frame: preoperatively, at 3-4 months postoperatively and at approximately 12 and 24 months postoperatively

    Clinical Results measured by Oswestry Disability Index (ODI). ODI contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel, each topic category is followed by 6 statements describing different potential scenarios in the patient's life relating to the topic. Each question is scored on a scale of 0 (indicating the least amount of disability) to 5 5 (indicating most severe disability). The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.

  3. Bone Fusion

    Time frame: at final follow-up approximately 24 months after surgery

    After Complex stabilization fusion of the treated segment is aspired in most cases. The fusion status can be determined from radiographs (static or dynamic). Bony fusion can be characterized quantitatively by the fusion rate.

  4. Cumulative number of Side effects

    Time frame: throughout the follow-up up to 24 months postoperatively

    Occurrence of complications potentially associated with the implanted devices can never be fully excluded during spinal surgery. In order to monitor potential complication and to identify so far unknown complications Adverse Events and Serious Adverse Events deemed related to the investigational device are recorded.

Study contacts

Contact information is provided by the study sponsor or research team.

Sarah Mattes

CONTACT

[email protected]

+497461950

Stefan Maenz

CONTACT

[email protected]

+497461950

Sponsors and collaborators

Lead sponsor

Aesculap AG

Industry

Collaborators

  • Raylytic GmbH

Registry information

Official study title

Multicenter Post Market Clinical Follow-Up (PMCF) Study on the Safety and Performance of Ennovate® Complex - A Prospective Study on Scoliosis Patients

Acronym: COSINE

Important dates

Study start
2022
Primary completion
2026
Study completion
2028
First posted
Mar 16, 2022
Registry last updated
Jun 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.